Quadnetics Group PLC
19 December 2005
Quadnetics Group plc
Purchase of Own Shares
Following the acquisition of Protec plc in an all-share offer, the Board of
Quadnetics Group plc ('Quadnetics') believes that the consolidated net cash
balances held by the Company are in excess of its immediate needs, although the
amount of the excess is still under review in the light of investment
opportunities that may emerge to support the continuing growth of its Synectics
digital security systems technology.
The Board also believes that the current market price of Quadnetics' ordinary
shares undervalues the Company's prospects, and therefore the purchase by the
Company of its own shares represents an attractive financial investment, and an
opportunity to increase earnings per share.
Accordingly, Quadnetics announces that it has purchased in the market today
37,731 of its own ordinary shares at a price of £2.00 under the authority
granted at the recent annual general meeting. On completion of the purchases,
these shares will be cancelled. The issued share capital following this purchase
is 15,425,848 shares.
ENDS
19 December 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.